4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0002132062-26-000004
Options or other derivatives
- Chief Medical Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Angelov Angel S Chief Medical Officer | 2026-05-18 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D: show line 1 in the form |
Loading xslF345X06/form4-05192026_080513.xml…